QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2022     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Anlotinib combined with induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A phase II study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Jiang, Feng;  Chen, Xiaozhong;  Liu, Tongxin;  Qin, WeiFeng;  Huang, Shuang 收藏  |  浏览/下载：8/0  |  提交时间：2022/12/23 Penpulimab plus gemcitabine in combination with cisplatin or anlotinib as first-line treatment for metastatic nasopharyngeal carcinoma (M NPC): A phase II study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Huang, Shuang;  Chen, Xiaozhong;  Qu, Song;  Qu, Shenhong;  Han, Yaqian 收藏  |  浏览/下载：11/0  |  提交时间：2022/12/23 Anlotinib plus radiotherapy-temozolomide for newly diagnosed glioblastoma: A prospective, multicenter phase II study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Lai, Shuzhen;  Chen, Yuan Yuan Yuan;  Li, Peijing;  Jiang, Fagui;  Liu, Xiaohui 收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23 A phase II study of anlotinib in the first-line treatment of locally advanced or metastatic soft-tissue sarcoma: Updated results. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Li, Tao;  Ye, Zhaoming;  Wei, Yongzhong;  Wang, Shoufeng;  Liu, Yunxia 收藏  |  浏览/下载：8/0  |  提交时间：2022/12/23 Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文 BMC PULMONARY MEDICINE, 2022, 卷号: 22 作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan 收藏  |  浏览/下载：17/0  |  提交时间：2022/12/23 Non-small cell lung cancer  Prognosis  Angiogenesis  Tyrosine kinase inhibitors   Anlotinib enhances the antitumor immunity of radiotherapy by activating cGAS 期刊论文 CELL DEATH DISCOVERY, 2022, 卷号: 8, 期号: 1 作者:  Dong Han;  Jiajia Zhang;  Yawei Bao;  Lei Liu;  Ping Wang 收藏  |  浏览/下载：0/0  |  提交时间：2024/05/07